Regencell Bioscience Holdings Limited (RGC)

RGC Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 9, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Cap	13,930	8,426	44	300	450	-
Market Cap Growth	2510.88%	19171.43%	-85.42%	-33.41%	-	-
Enterprise Value	14,017	8,421	35.79	288.24	434.21	0
Last Close Price	28.17	17.04	0.09	0.61	0.91	-
PE Ratio	-	-2366.67	-10.16	-50.95	-59.66	-
PB Ratio	2884.86	1733.67	5.32	24.92	26.38	-
P/TBV Ratio	2866.04	1733.67	5.32	24.92	25.96	-
P/FCF Ratio	-	-2579.73	-10.91	-60.08	-74.45	-
P/OCF Ratio	-	-2706.24	-10.93	-60.41	-85.48	-
EV/EBITDA Ratio	-	-2493.58	-8.97	-52.37	-61.91	-
EV/EBIT Ratio	-	-2233.81	-7.56	-45.94	-57.00	-
EV/FCF Ratio	-	-2578.30	-8.93	-57.76	-71.79	-
Debt / Equity Ratio	0.05	0.05	0.00	0.00	0.02	-0.92
Debt / EBITDA Ratio	-0.16	-0.16	-0.02	-0.08	-0.11	-2.72
Debt / FCF Ratio	-0.17	-0.17	-0.02	-0.09	-0.13	-4.80
Net Debt / Equity Ratio	-0.90	-0.90	-0.96	-0.92	-0.92	-0.91
Net Debt / EBITDA Ratio	1.29	1.29	1.97	2.02	2.23	-2.67
Net Debt / FCF Ratio	1.33	1.33	1.97	2.23	2.59	-4.72
Quick Ratio	7.38	7.38	41.13	19.06	28.41	0.01
Current Ratio	7.39	7.39	41.92	19.15	28.46	0.02
Return on Equity (ROE)	-61.93%	-54.81%	-43.18%	-41.71%	-116.10%	40.51%
Return on Assets (ROA)	-56.97%	-53.12%	-44.98%	-40.95%	-82.99%	-323.45%
Return on Invested Capital (ROIC)	-94.37%	-874.85%	-757.56%	-534.00%	-1315.08%	1061.65%
Return on Capital Employed (ROCE)	-59.98%	-56.54%	-46.76%	-42.60%	-113.33%	41.55%
Earnings Yield	-0.03%	-0.04%	-9.84%	-1.96%	-1.68%	-
FCF Yield	-0.02%	-0.04%	-9.16%	-1.66%	-1.34%	-
Buyback Yield / Dilution	-	0.00%	0.00%	-1.62%	-28.06%	0.00%
Total Shareholder Return	-	0.00%	0.00%	-1.62%	-28.06%	0.00%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q